Mar 06, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.
Mar 06, 2019 - J&J (JNJ) gets FDA nod for its new nasal spray, Spravato (esketamine) for treatment-resistant depression
Mar 04, 2019 - The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, JPMorgan, Sun Life and Evergy
Mar 03, 2019 - These biopharmaceutical startups have been losing their investors' money for decades.
Mar 01, 2019 - Top Stock Reports for Facebook, Johnson & Johnson & JPMorgan
Feb 28, 2019 - These three titans of their respective industries should be able to weather nearly any market environment.
Feb 27, 2019 - A Senate committee roasted top executives of the biggest drugmakers. But will anything change for ordinary Americans?
Feb 27, 2019 - Theravance Biopharma (TBPH) incurs narrower-than-expected loss in Q4. The top line surpasses estimates.
Feb 27, 2019 - Chardan Capital Markets reiterates its Buy rating on gene therapy developer MeiraGTx (MGTX +14.4%) with a more bullish price target of $40 (165% upside) (from $30) after it announced a stake by a grou
Feb 26, 2019 - Top drug companies addressed sky-high drug prices on Capitol Hill today.